Qiagen NV | QIA - Sales Revenues

Stock Price
43.17
Daily Change
-0.31 -0.70%
Monthly
1.90%
Yearly
8.86%
Q1 Forecast
43.53

Qiagen NV reported $457.38M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
argenx SE USD 987.09M 144.59M Sep/2025
Avita Medical AUD 18.42M 14K Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Moderna USD 1.02B 878M Sep/2025
Organon & Co USD 1.6B 10M Sep/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.76B 190M Sep/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025